|
|
|
 |
|
PerkinElmer : Proteomics Precisely
PerkinElmer has brought together core expertise from across the whole of the Corporation to create a gel-based proteomics platform, which offers highest precision of performance coupled with the sample tracking capabilities that customers now demand.
We offer the synergy and precision combination of novel SuperBRIGHT chemistry, ProXPRESS 1-D/2-D gel imaging, and Progenesis fast, fully-automated gel analysis.
ProPic is acclaimed as the highest accuracy protein gel cutter while MultiProbe Proteomics provide today’s best solution for proteolytic digestion and spotting onto MALDI targets.
PerkinElmer’s joint venture with MDS Sciex has resulted in the Condor MALDI-TOF MS.
Visit our website to learn more: http://las.perkinelmer.com/catalog/Category.aspx?CategoryName=Proteomics
|
|
 |
Applied Biosystems
Applied Biosystems is the leading supplier of life science technologies. We develop, market and support systems consisting of instruments, reagents and software that are used in basic life science research, pharmaceutical research and development, diagnostics, forensics and food testing. With sales of over $1.6 billion in fiscal year 2001 and systems in over 30,000 laboratories in over 150 countries, Applied Biosystems has had a broad impact on the evolution of biology in the last 20 years. We fuel our technology and market leadership position with investments in internal research and development that exceeded $150 million in the last fiscal year. This investment is augmented with relationships with a variety of partners including small companies and universities with special expertise and larger companies with complementary capabilities.
Visit our website to learn more: http://home.appliedbiosystems.com |
|
|
|
Geneva Bioinformatics (GeneBio) S.A.
Shaping Biological Knowledge
Building on our existing assets and experience in the field of proteomics data generation and management, our focus at GeneBio is to offer our clients original solutions that shape heterogeneous information into relevant biological knowledge.
Since our inception in 1997 by Ron Appel, Amos Bairoch, and Denis Hochstrasser, all eminent scientists in the fields of bioinformatics and proteomics, we have evolved from our initial mandate to commercialise products developed and maintained by the Swiss Institute of Bioinformatics (SIB) into a multifaceted bioinformatics company placing a strong emphasis on adherence to scientific excellence and innovation towards long-term sustainability.
Through strategic alliances with key research organisations, in-house development and the know-how of our scientists we apply our efforts to the following activities:
Discovery
GeneBio proposes an innovative approach to deal with biological information, considering it as dynamically networked in mechanism-dependent scenarios. We make the most of our scientists‘ know-how in protein annotation to develop innovative solutions that refine and rationalize biological knowledge for research in the life sciences, through the linking of genomics, proteomics, clinical and other data. In particular, we attempt to identify and cross-link context-sensitive information that characterizes protein structure, function and modifications. In addition, we distribute leading knowledge databases that provide a high-level of annotation as well as in-depth up-to-date information
Training
Genebio is addressing the increasing demand for comprehensive and easily accessible proteomics-based bioinformatics intelligence. We make the most of our expertise to offer clients the ability to have a more complete, up-to-date perspective and a better understanding of the bioinformatics field. Above all, we provide a unique first-hand insight into the capabilities of the renowned SWISS-PROT knowledgebase and its linked information resources and tools.
Visit our website to learn more: www.genebio.com |
|
 |
|
|
|
|
|
 |
|
 |
|
|
|
|
© Swiss Proteomics Society
|
FontisMedia SA
|
|
|
|
|
